0001415889-14-003736.txt : 20141126
0001415889-14-003736.hdr.sgml : 20141126
20141126182902
ACCESSION NUMBER: 0001415889-14-003736
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141126
FILED AS OF DATE: 20141126
DATE AS OF CHANGE: 20141126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11085 TORREYANA ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 11085 TORREYANA ROAD
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mills Roger
CENTRAL INDEX KEY: 0001368190
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 141254698
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BOULEVARD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
form4-11262014_031154.xml
X0306
4
2014-11-26
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001368190
Mills Roger
11085 TORREYANA ROAD #100
SAN DIEGO
CA
92121
false
true
false
false
EVP, DEVELOPMENT AND CMO
Common Stock
2014-11-26
4
M
0
25000
0
A
43550
D
Common Stock
2014-11-26
4
S
0
25000
30.0906
D
18550
D
Stock Option (right to buy)
1.55
2014-11-26
4
M
0
25000
0
D
2020-03-11
Common Stock
25000
139035
D
Includes 916 shares acquired on November 29, 2013 and 1,859 shares acquired on May 30, 2014 by Dr. Mills under the ACADIA Pharmaceuticals Employee Stock Purchase Plan.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.18 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
/s/ Glenn F. Baity, Attorney-in-Fact
2014-11-26